MARY FLANAGAN: Open Payments
NPI 1033763297 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,224 in 16 payments from 8 companies in 2025. Trend: 2023 $1,747 · 2024 $2,460 · 2025 $2,224
Consulting: $1,190Food & beverage: $1,017Education: $17
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 3 | $1,242 |
| Daiichi Sankyo Inc. | 3 | $269 |
| JAZZ PHARMACEUTICALS INC. | 2 | $240 |
| AstraZeneca Pharmaceuticals LP | 3 | $143 |
| Genmab U.S., Inc. | 1 | $110 |
| Janssen Biotech, Inc. | 1 | $110 |
| Syndax Pharmaceuticals, Inc. | 1 | $67 |
| Gilead Sciences, Inc. | 2 | $44 |
Products named: RYBREVANT, ZEPZELCA, Enhertu, DATROWAY, Trodelvy, TAGRISSO.
Industry payments across MO — which companies pay providers there.
